22nd Century Group Vs. Kymera Therapeutics Industry Stock Comparison

Sell

13

XXII
22nd Century Group

Last Price:

0.10

Seasonality Move:

25.95%

Buy

62

KYMR
Kymera Therapeutics

Last Price:

46.17

Seasonality Move:

69.6%

Sell

13

22nd Century Group (XXII) is a Sell

Is 22nd Century Group a Buy, Sell or Hold?

The current 22nd Century Group [XXII] share price is $0.10. The Score for XXII is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
XXII is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
This Score is currently showing an extreme reading that indicates risk could be especially high.

Buy

62

Kymera Therapeutics (KYMR) is a Buy

Is Kymera Therapeutics a Buy, Sell or Hold?

The current Kymera Therapeutics [KYMR] share price is $47.65. The Score for KYMR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
KYMR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

XXII Stock Price Chart

What is 22nd Century Group's stock price today?

The 22nd Century Group share price today is $0.10
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XXII is experiencing slight buying pressure.

KYMR Stock Price Chart

What is Kymera Therapeutics's stock price today?

The Kymera Therapeutics share price today is $47.65
The current trend is moderately bearish and KYMR is experiencing slight selling pressure.

XXII Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.05	Sell
Relative Strength Index (14 RSI):	28.57	Sell
Chaikin Money Flow:	-4028473	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.11 - 0.21)	Sell
Bollinger Bands (100):	(0.23 - 0.73)	Sell

KYMR Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.6	Buy
Relative Strength Index (14 RSI):	52.44	Buy
Chaikin Money Flow:	-88534	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(44.05 - 49.09)	Buy
Bollinger Bands (100):	(36.61 - 48.91)	Buy

XXII Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.11	Sell
20-day SMA:	0.14	Sell
50-day SMA:	0.25	Sell
200-day SMA:	1.25	Sell
8-day EMA:	0.11	Sell
20-day EMA:	0.15	Sell
50-day EMA:	0.28	Sell
200-day EMA:	10.14	Sell

KYMR Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	48.2	Sell
20-day SMA:	46.01	Buy
50-day SMA:	47.06	Buy
200-day SMA:	39.57	Buy
8-day EMA:	47.93	Sell
20-day EMA:	47.19	Buy
50-day EMA:	46.06	Buy
200-day EMA:	39.32	Buy

22nd Century Group Earnings Growth & XXII Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.44 per share, and an increase next year of $0.92 per share.

Kymera Therapeutics Earnings Growth & KYMR Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.

22nd Century Group Technical Analysis

	Oct 16	Oct 18	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30
	Oct
	16	18	21	22	23	24	25	28	29	30
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Kymera Therapeutics Technical Analysis

	Oct 16	Oct 18	Oct 21	Oct 22	Oct 23	Oct 24	Oct 25	Oct 28	Oct 29	Oct 30
	Oct
	16	18	21	22	23	24	25	28	29	30
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):